Oncology Institute (TOI) Acquisitions (2021 - 2023)

Oncology Institute has reported Acquisitions for 3 years, with the latest figure at $156000.0 in Q4 2023.

• For the quarter ending Q4 2023, Acquisitions fell 66.81% year-over-year to $156000.0; the trailing twelve-month figure through Dec 2024 stood at $156000.0 (up 183.42% YoY), and the FY2023 full-year result was $4.5 million, down 48.05% from the prior year.
• Acquisitions for Q4 2023 stood at $156000.0, down from $470000.0 in the prior quarter.
• The five-year high for Acquisitions was $8.9 million in Q2 2022, with the low at -$813000.0 in Q3 2022.
• Historically, Acquisitions has averaged $3.0 million across 3 years, with a median of $648500.0 in 2021.
• Annual changes were most pronounced in 2022 — Acquisitions tumbled 94.32% — and 2023, when it sank 66.81%.
• Oncology Institute's Acquisitions stood at $8.3 million in 2021, then plunged by 94.32% to $470000.0 in 2022, then slumped by 66.81% to $156000.0 in 2023.
• The last three Acquisitions figures came in at $156000.0 (Q4 2023), $470000.0 (Q4 2022), and -$813000.0 (Q3 2022), per Business Quant data.